Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB

Laboratory Investigation

Volumn 92, Issue 4, 2012, Pages 615-624

  Lisi, Sabrina ^a   Sisto, Margherita ^a   Lofrumento, Dario Domenico ^b   D'Amore, Massimo ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

anti Ro SSA autoantibodies; I B ; NF B; Sj gren's syndrome; TACE; TNF

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR1; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; METALLOPROTEINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; RO ANTIBODY; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE EXACERBATION; DNA BINDING; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MICRODISSECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SALIVARY GLAND; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME;

ADAM PROTEINS; ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; DIPEPTIDES; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION; HUMANS; HYDROXAMIC ACIDS; I-KAPPA B PROTEINS; MIDDLE AGED; NF-KAPPA B; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859351330     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.190     Document Type: Article

References (39)

1. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008;132:344-362.
2. Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther 2008;10:212.
3. Roescher N, Tak PP, Illei GG. Cytokines in Sjögren's syndrome. Oral Dis 2009;15:519-526.
4. Fox RI, Kang HI, Ando D, et al. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 1994;152:5532-5539. (Pubitemid 24153003)
5. Nikolov NP, Illei GG. Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 2009;21:465-470.
6. Cuello C, Palladinetti P, Tedla N, et al. Chemokine expression and leucocyte infiltration in Sjögren's syndrome. Br J Rheumatol 1998;37: 779-783.
7. Sisto M, Lisi S, Lofrumento DD, et al. Expression of pro-inflammatory TACE-TNF-α-amphiregulin axis in Sjögren's syndrome salivary glands. Histochem Cell Biol 2010;134:345-353.
8. Lisi S, Sisto M, Lofrumento DD, et al. Pro-inflammatory role of anti-Ro/ SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. J Autoimmun 2010;35:160-170.
9. Ewert P, Aguilera S, Alliende C, et al. Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum 2010;62: 1280-1289.
10. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999;19:201-211. (Pubitemid 29500267)
11. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 1997;385:729.
12. Moss ML, Jin SL, Becherer JD, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 1997;385:733.
13. Sisto M, Lisi S, Lofrumento DD, et al. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies. Immunobiology 2010;215:874-883.
14. Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res 2005;15:24-27.
15. Madrigal JL, Hurtado O, Moro MA, et al. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 2002;26:155-163. (Pubitemid 34093078)
16. Bigdeli MR, Khoshbaten A. In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-alpha converting enzyme/tumor necrosis factor-alpha/ nuclear factor-kappaB. Neuroscience 2008;153:671-678.
17. Zheng C, Yin Q, Wu H. Structural studies of NF-κB signaling. Cell Res 2011;21:183-195.
18. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. European Study Group on Classification Criteria for Sjögren's Syndrome. Ann Rheum Dis 2002;61:554-558. (Pubitemid 34539104)
19. Sisto M, Lisi S, Castellana D, et al. Autoantibodies from Sjögren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun 2006;27:38-49. (Pubitemid 44294853)
20. Lisi S, Sisto M, Soleti R, et al. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253. J Oral Pathol Med 2007;36:511-523. (Pubitemid 47390145)
21. Sens DA, Hintz DS, Rudisill MT, et al. Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab Invest 1985;52:559-567. (Pubitemid 15065730)
22. Sisto M, Lisi S, Lofrumento DD, et al. A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome. Histochem Cell Biol 2011;135:615-625.
23. Crowe PD, Walter BN, Mohler KM, et al. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 1995;181:1205-1210.
24. Coward WR, Okayama Y, Sagara H, et al. NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 2002; 169:5287-5293. (Pubitemid 35217201)
25. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008;29:258-289.
26. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62. (Pubitemid 46012014)
27. Lisi S, D'Amore M, Lofrumento D, et al. Modulation of the Fc gamma receptors induced by anti-Ro and anti-La autoantibodies: observations in salivary gland cells. Rheumatol Int 2008;28:943-948.
28. Sisto M, Lisi S, D'Amore M, et al. Anti-Ro and anti-La autoantibodies induce TNF-alpha production by human salivary gland cells: an in vitro study. Reumatismo 2007;59:221-226.
29. Hayakawa K, Meng Y, Hiramatsu N, et al. Spontaneous activation of the NF-kappaB signaling pathway in isolated normal glomeruli. Am J Physiol Renal Physiol 2006;291:F1169-F1176. (Pubitemid 44887229)
30. Syed MM, Phulwani NK, Kielian T. Tumor necrosis factor-alpha (TNF-alpha) regulates Toll-like receptor 2 (TLR2) expression in microglia. J Neurochem 2007;103:1461-1471. (Pubitemid 47631804)
31. Arribas J, Esselens C. ADAM17 as a therapeutic target in multiple diseases. Curr Pharm Des 2009;15:2319-2335.
32. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-a in disease states and inflammation. Crit Care Med 1993;21:S447-S463. (Pubitemid 23304335)
33. Newton RC, Solomon KA, Covington MB, et al. Biology of TACE inhibition. Ann Rheum Dis 2001;60:iii25-iii32. (Pubitemid 32980439)
34. Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med 2008;263:591-596.
35. Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2006;14:839-848. (Pubitemid 44138675)
36. Valéro R, Baron ML, Guérin S, et al. A defective NF-kappa B/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells. J Immunol 2002;169:185-192. (Pubitemid 34686135)
37. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-734.
38. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109(Suppl):S81-S96.
39. Chiao PJ, Miyamoto S, Verma IM. Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci USA 1994;91:28-32.